Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation
Raloxifene HCl belongs to a class of selective estrogen receptor modulators (SERMs) which is used for the management of breast cancer. The major problem reported with raloxifene is its poor bioavailability which is only up to 2%. The main objective of the present work was to formulate raloxifene loa...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English English |
| Published: |
Elsevier B.V.
2018
|
| Subjects: | |
| Online Access: | http://umpir.ump.edu.my/id/eprint/20675/1/Transdermal%20delivery%20of%20raloxifene%20HCl%20via%20ethosomal%20system_%20Formulation%2C%20advanced%20characterizations%20and%20pharmacokinetic%20evaluation.pdf http://umpir.ump.edu.my/id/eprint/20675/7/Transdermal%20delivery%20of%20raloxifene%20HCl%20via%20ethosomal%20system.%20Formulation%2Cadvanced%20characterizations%20and%20pharmacokinetic%20evaluation.pdf |
Internet
http://umpir.ump.edu.my/id/eprint/20675/1/Transdermal%20delivery%20of%20raloxifene%20HCl%20via%20ethosomal%20system_%20Formulation%2C%20advanced%20characterizations%20and%20pharmacokinetic%20evaluation.pdfhttp://umpir.ump.edu.my/id/eprint/20675/7/Transdermal%20delivery%20of%20raloxifene%20HCl%20via%20ethosomal%20system.%20Formulation%2Cadvanced%20characterizations%20and%20pharmacokinetic%20evaluation.pdf